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Abstract
Background: Vitamin A (VA) has a key role in vertebrate morphogenesis, determining body patterning and growth
through the control of cell proliferation and differentiation processes. VA regulates primary molecular pathways of
those processes by the binding of its active metabolite (retinoic acid) to two types of specific nuclear receptors:
retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which promote transcription of downstream target
genes. This process is well known in most of higher vertebrates; however, scarce information is available regarding
fishes. Therefore, in order to gain further knowledge of fish larval development and its disruption by nutritional VA
imbalance, the relative expression of some RARs and RXRs, as well as several genes involved in morpho- and
skeletogenesis such as peroxisome proliferator-activated receptors (PPARA, PPARB and PPARG); retinol-binding
protein (RBP); insulin-like growth factors I and II (IGF1 and IGF2, respectively); bone morphogenetic protein 2
(Bmp2); transforming growth factor b-1 (TGFB1); and genes encoding different extracellular matrix (ECM) proteins
such as matrix Gla protein (mgp), osteocalcin (bglap), osteopontin (SPP1), secreted protein acidic and rich in
cysteine (SPARC) and type I collagen a1 chain (COL1A1) have been studied in gilthead sea bream.
Results: During gilthead sea bream larval development, specific expression profiles for each gene were tightly
regulated during fish morphogenesis and correlated with specific morphogenetic events and tissue development.
Dietary hypervitaminosis A during early larval development disrupted the normal gene expression profile for genes
involved in RA signalling (RARA), VA homeostasis (RBP) and several genes encoding ECM proteins that are linked to
skeletogenesis, such as bglap and mgp.
Conclusions: Present data reflects the specific gene expression patterns of several genes involved in larval fish RA
signalling and skeletogenesis; and how specific gene disruption induced by a nutritional VA imbalance underlie the
skeletal deformities. Our results are of basic interest for fish VA signalling and point out some of the potential
molecular players involved in fish skeletogenesis. Increased incidences of skeletal deformities in gilthead sea bream
fed with hypervitaminosis A were the likely ultimate consequence of specific gene expression disruption at critical
development stages.
Background
Skeletogenesis is a critical process in vertebrates during
which the skeleton develops in a genetically programmed
manner, leading to normal anatomy that provides support
and protection for the internal organs. In mammals, this
process includes the differentiation and proliferation of
different cell types, such as chondrocytes, osteoblasts,
osteocytes and osteoclasts, which determine the size,
shape and mineral composition of bone structures. The
expression of specific genes deeply underlies these pro-
cesses of cell proliferation and differentiation, which are
also controlled by biotic and abiotic factors as well as indi-
vidual genetic characteristics. Thus, determining factors
and conditions that control and perturb those processes at
the transcriptional level could be useful for deciphering
the specific mechanisms behind these processes.
Teleost fish are considered to be the first vertebrate
group to develop a bony skeleton, and with it, the
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molecular machinery necessary for its formation and
maintenance. Thus, fish have been recognized as a suita-
ble vertebrate model for understanding skeletogenesis in
lower and higher vertebrates for both comparative [1]
and evolutionary [2] purposes. In addition, marine fish
larvae hatch much earlier in their development than
other vertebrates, suggesting that the spatiotemporal
sequences of the skeletal development in teleosts are
quite different from those of higher vertebrates [3]. This
makes marine fish species a very interesting model to
study the influence of several nutrients, such as vitamin
A, in morphogenesis and skeletogenesis during early lar-
val development [4].
Nutritional research has recently focused on the role
of nutrients on gene expression and regulation (nutrige-
nomics) [5]. The main pathway by which some nutrients
control gene expression is by the activation of transcrip-
tion factors, with the nuclear receptor superfamily being
one of the most important. Within this family, the reti-
noic acid receptors (RARs) and retinoid X receptors
(RXRs) are the specific receptors that transduce the vita-
min A (VA) signalling by binding to their specific
ligands, the retinoic acid isomers. RARs and RXRs have
been found in all vertebrate tissues examined, and
within both are present three different isotypes (a, b
and g), each one encoded by a separate gene. These
RARs and RXRs bind to retinoic acid (RA, the main
active metabolite of VA), becoming ligand-activated
receptors. Then, they form homo- and/or heterodimers
that bind to specific nucleotide sequences (retinoic acid
response elements, RAREs) in the promoter region of a
large number of genes [6,7], regulating their transcrip-
tional activity. These RARs and RXRs can also affect
indirectly the transcription of many other genes without
any RARE in their promoter [6]. Then, through those
molecular pathways, RA plays a key role in morphogen-
esis, cellular proliferation and differentiation processes
of bone formation [8].
Skeletogenesis has been extensively described in sev-
eral marine fish species [9-12], but gene expression pat-
terns during larval development have only been partially
characterized in European sea bass (Dicentrarchus lab-
rax; [13,14]) and gilthead sea bream (Sparus aurata;
[15]). In addition, studies have shown that fish fed diets
with deficient or excess VA content had compromised
development, showing reduced growth and survival rate,
delayed digestive system maturation and high incidence
of skeletal deformities [16-22]. However, while most
reports are related to the consequences of dietary VA
imbalance, limited work has focused on the molecular
pathways involved in retinoid homeostasis that leads to
an abnormal fish phenotype [23]. Moreover, such works
have focused mainly on embryonic development rather
than larval development [24-26]. Therefore, following
our previous work on the description of abnormal phe-
notypes in gilthead sea bream larvae fed with hypervita-
minosis A [18], in the present study we evaluated the
relative expression of several genes involved in gilthead
sea bream morpho- and skeletogenesis during larval
development, and their disruption when fish were fed
with high VA doses. In addition to retinoic acid recep-
tors (RARA, RARG and RXRB), we evaluated the expres-
sion of different genes interacting with the RA signalling
pathway, such as peroxisome proliferator-activated
receptors (PPARA, PPARB and PPARG) that act as regu-
lators of lipid and lipoprotein metabolism, glucose
homeostasis, cellular proliferation and differentiation, as
well as apoptosis in mammals [27]; the gene encoding
retinol-binding protein (RBP) as the main protein that
specifically transports retinol from liver to peripheral tis-
sues [28]; and insulin-like growth factors I and II (IGF1
and IGF2, respectively), which control cell growth and
proliferation. Bone morphogenetic protein 2 (Bmp2) and
transforming growth factor b-1 (TGFB1) were also stu-
died as they are key transcriptional factors for normal
development [29], controlling the production of differ-
ent extracellular matrix (ECM) proteins of bone. Addi-
tionally, relative expression of genes encoding different
ECM proteins was evaluated such as matrix Gla protein
(mgp) and osteocalcin (bglap, also known as bone Gla
protein) as important regulators of calcium metabolism
and skeletal development; osteopontin (SPP1) and
secreted protein acidic and rich in cysteine (SPARC), as
examples of important matricellular proteins acting as
modulators of ECM interactions; and type I collagen a1
chain (COL1A1), which represents 90% of collagen pro-
teins in bone tissues. Present results, describing the
expression of several genes involved in gilthead sea
bream morpho- and skeletogenesis processes under
standard larval rearing conditions and their disruption
of expression under hypervitaminosis A regimens, are of
basic interest for understanding normal skeletogenesis
and the appearance of skeletal deformities, as well as a
tool for assessing fish nutritional VA imbalance.
Results
Gilthead sea bream larval growth and bone
mineralization
Larval growth in standard length (SL) and dry weight
(DW) under standard rearing conditions are presented in
Figure 1. Growth in DW and SL shows the typical expo-
nential and linear increase with age, respectively. Growth
performance of larval rearing under hypervitaminosis A
conditions was affected by the level of dietary VA [18].
Whereas no clear effects were found in larval SL at 18
days post hatch (dph), larvae fed with the highest dietary
VA content (10×VA; 10- fold VA increase in relation to
the control diet) were significantly smaller (7%) than the
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control group at 60 dph. Similarly, no differences in DW
were found between experimental groups at 18 dph,
while at 60 dph 10×VA larvae (56.86 ± 11.27 mg) pre-
sented a reduction of 27% in DW with respect to control
and 1.5×VA (1.5-fold VA increase in relation to the con-
trol diet) larvae (74.61 ± 8.84 and 69.31 ± 10.24 mg,
respectively).
Regarding the bone mineralization of larvae, bone and
cartilage staining quantification performed by IMAQ
Vision Builder is summarized in Figure 2. Mineralization
values were expressed as the ratio of red/blue colour as
well as the specific amounts of each colour per larval sur-
face, from stained fish for each experimental group. There
were three patterns observed (Figure 3): (i) in control lar-
vae most of the structures were red coloured with the
exception of few structures (mainly pterygiophores and
sclerotic related structures); (ii) the 1.5×VA larvae had
many structures quite blue in colouration (pectoral and
caudal fin related structures, pterygiophores, and splanch-
nocranium related structures such as frontral, pterotic,
sphenotic and sclerotic related structures); and (iii) in the
10×VA larvae blue colouration was intermediate with
respect to the previously enumerated structures of 1.5×VA
larvae (skeletal structure nomenclature was as in [9-11]).
Mineralization values in 1.5×VA and 10×VA larvae at 60
dph were higher than in the control group, although there
were no significant differences (ANOVA, P > 0.05; Figure
2a). The absence of a statistically significant difference
between treatments is likely due to the high variability
observed among replicates from each treatment. Interest-
ingly, significantly higher cartilage staining was found in
1.5×VA and 10×VA larvae with respect to the control
group (ANOVA; P < 0.05; Figure 2b). In addition, the
ratio of red/blue coloration (bone/cartilage mineralization)
showed that both larvae fed with VA supplemented diets
(1.5×VA and 10×VA) had lower values than the control
group; although this tendency was not statistically signifi-
cant (ANOVA, P > 0.05; Figure 2c).
Gene expression patterns during gilthead sea bream
ontogeny development under standard rearing
conditions
During larval development, RA nuclear receptors, RARA,
RARG and RXRB, exhibited different expression patterns
in gilthead sea bream (Figure 4). Under our rearing
Figure 1 Gilthead sea bream larval growth from 2 to 60 dph.
Growth in standard length (long dash line) was measured in mm
and weight in mg dry weight (solid line). Values are expressed as
mean ± standard deviation. Equation of the linear regression for the
growth in standard length was y = 1,6562x - 0,666 (R2 = 0,9112),
while the exponential regression line for the growth in dry weight
was y = 0,0252e0,8815x (R2 = 0,9614).
Figure 2 Gilthead sea bream bone mineralization at 60 dph of
fishes from the different dietary treatments. Bone mineralization
measured as ratios of red pixels (a), blue pixels per larval surface (b),
and red pixels over blue pixels (c). Ratios are expressed as mean ±
standard deviation. Letters denotes significant differences between
dietary groups (ANOVA, P < 0.05; n = 26 larvae per treatment). C,
larvae fed with control diet (0.66*108 total VA IU kg-1 DW); 1.5×VA,
larvae fed with 1.5 fold increase in dietary VA content (1.00*108 total
VA IU kg-1 DW); 10×VA, larvae fed with 10 fold increase in dietary
VA content (6.82*108 total VA IU kg-1 DW).
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Figure 3 Examples of double stained fish with alcian blue/alizarin red from different dietary treatments showing different levels of
ossifications and typologies of skeletal deformities. (a) Larva fed with control diet (0.66*108 total VA IU kg-1 DW) exhibiting mostly red
coloured skeletal structures (calcified bone) with the exception of pterygiophores and sclerotic elements still stained with alcian blue (cartilage). (b)
Larva fed moderately increased levels of VA (1.5×VA group, 1.00*108 total VA IU kg-1 DW) showing a larger proportion of skeletal structures stained in
blue (cartilage) in comparison to the control group; e.g. pectoral fin girdle, epurals, parahypural and specialized neural arch in the caudal fin complex,
and frontal, pterotic and parietal bones in the cranium. (c) Larva fed with the highest levels of VA (10×VA group, 6.82*108 total VA IU kg-1 DW)
showing intermediate values in blue colouration with regards to the control group. The skeletal structures stained in blue (cartilage) are those already
reported in the larva from the 1.5×VA group. (d) Larva showing a severe deformity (double lordosis and kyphosis) affecting haemal vertebrae. (e)
Deformed caudal fin complex showing the fusion of the hypurals 3-4 (HF3-4) and 1-2 (HF1-2), as well as the fusion (VF) and compression (VC) of
different haemal vertebrae centra (23-24 and 22-23, respectively). (f) Fusion of vertebral bodies (VF) from haemal vertebrae number 22 and 23 and
underdevelopment of vertebrae 24 (UV). (e) Head of a larva with a slight prognathism (asterisk) due to an underdevelopment of the premaxillar and
maxillar bones, and vertebral compression (VC) between centra of prehaemal vertebrae number 2 and 3.
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conditions, gilthead sea bream larvae showed a high
overall level of RARA gene expression until 10 dph, after
which levels decreased significantly and thereafter
remained constant until the end of the experiment (60
dph) (ANOVA, P < 0.05; Figure 4a). Conversely, the
expression of RARG and RXRB were lower during the
initial larval development, after which the levels
increased. However, while RARG increased significantly
from 29 dph, with a peak at 37 dph (1.8 fold change
compared to 2 dph), its expression level significantly
decreased at 60 dph (ANOVA, P < 0.05; Figure 4b) with
respect to the levels at 37 dph. The expression of RXRB
increased significantly only between 29 and 60 dph
(ANOVA, P < 0.05; Figure 4c).
There were no significant differences in the RBP gene
expression profile during the larval development
(ANOVA, P > 0.05; Figure 5a). PPARA expression was
constant from 2 to 37 dph, whereas at 45 dph a peak of
gene expression was noted (2.94 fold increase with
respect to 2 dph larvae; P < 0.05; Figure 5b). PPARB
expression remained constant from 2 to 60 dph
(ANOVA, P > 0.05; Figure 5c). The PPARG expression
level did not change from 2 to 52 dph; however, at the
end of the study (60 dph), expression values were signif-
icantly higher than those mostly observed between 7
and 37 dph (ANOVA, P < 0.05; Figure 5d), but not sig-
nificantly different to those observed at 2 dph.
Overall, the IGF1 and IGF2 gene expression had sig-
nificantly increased at the end of larval development.
However, while IGF1 gene expression increased signifi-
cantly and progressively from 0.54 at 7 dph to 6.52 at
60 dph (ANOVA, P < 0.05; Figure 5e), IGF2 expression
remained constant from 2 to 29 dph (ANOVA, P >
0.05; Figure 5f). Expression values of IGF2 increased sig-
nificantly between 37 and 45 (1.43 ± 0.06 mean expres-
sion ratio; ANOVA, P < 0.05; Figure 5f) and remained
constant until the end of the study. Bmp2 did not show
significant variations in its mean gene expression ratio
throughout larval development (ANOVA, P > 0.05),
although a tendency for higher expression values was
observed from 37 dph onwards (Figure 5g). Interest-
ingly, TGFB1 presented an overall significant increase in
its gene expression ratio from 29 dph until the end of
the trial (ANOVA, P < 0.05; Figure 5h).
With respect to the expression patterns of genes
encoding ECM proteins during larval development, all
of them increased at the end of the study. However, the
mean gene expression ratios reached at the end of the
experiment by each gene were different. The genes mgp
and bglap showed the highest mean expression ratios at
60 dph (199.38 and 7956.15, respectively; ANOVA, P <
0.05; Figure 6a,b). In both Gla protein genes, a signifi-
cant increase in the mean gene expression ratio was
observed near the end of the trial (around 45 dph). In
contrast, SPP1 and SPARC showed lower mean values
(23.38 and 3.25, respectively) at the end of the experi-
ment (Figure 6c and 6d, respectively) compared with
mgp and bglap ratios, although presenting significant
increases as well in comparison to results from early lar-
val stages (ANOVA, P < 0.05). Furthermore, both SPP1
and SPARC showed a significant increase at 37 dph in
their mean gene expression ratios, earlier than mgp and
Figure 4 Ontogenetic gene expression patterns of RARA (a),
RARG (b) and RXRB (c). Gene expression measured as the mean
expression ratio of the target gene with respect to the house-
keeping gene (EF1a) at each sample time compared with initial
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Figure 5 Ontogenetic gene expression patterns of RBP (a), PPARA (b), PPARB (c), PPARG (d), IGF1 (e), IGF2 (f), Bmp2 (g), and TGFB1 (h).
Gene expression measured as the mean expression ratio of the target gene with respect to the house-keeping gene (EF1a) at each sample time
compared with initial sample time (2 dph). Different letters denote significant differences of the global gene expression (ANOVA, P < 0.05; n = 3).
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bglap. Finally, COL1A1 presented a similar gene expres-
sion profile to those of other ECM protein genes, with a
significant increase in the mean gene expression ratio at
60 dph (ANOVA, P < 0.05; Figure 6e).
Global hierarchical clustering was applied on the gene
expression ratios during larval development for the 16
studied genes (Figure 7). This clustering was used to
classify genes on the basis of similarity of their expres-
sion profile during larval development sampling times.
Two gene clusters were found: (i) genes whose mean
gene expression level increased from 37 dph, such as
IGF1, TGFB1, RXRB, IGF2 and genes encoding extracel-
lular matrix proteins (mgp, bglap, SPP1, SPARC and
COL1A1); and (ii) genes whose mean gene expression
ratio decreased progressively from an initial relatively
high level of expression (PPARB, RARA and RBP).
Gene expression in gilthead sea bream larvae fed with
increasing levels of dietary VA
At 18 dph, larvae fed with increasing dietary VA levels
exhibited disruption in the expression of several studied
genes. While some of them showed an up-regulation,
others were down-regulated with respect to the control
feeding regime. That gene disruption was also noted in
some genes even when the dietary VA imbalance had
finished more than 40 days before (60 dph).
Figure 6 Ontogenetic gene expression patterns of mgp (a),
bglap (b), SPP1 (c), SPARC (d), and COL1A1 (e). Gene expression
measured as the mean expression ratio of the target gene respect
to the house-keeping gene (EF1a) at each sample time compared
with initial sample time (2 dph). Different letters denote significant
differences of the global gene expression (ANOVA, P < 0.05; n = 3).
Figure 7 Hierarchical clustering of the 16 target genes
analysed based on mRNA expression, showing the cluster of
the different studied genes with similar expression profile
during larval development. Columns represent the mean data
values for each of the 10 sampling times (days post hatching; dph)
and rows represent single genes. Expression level of each gene is
represented relative to its median abundance across the different
stages and is depicted by a colour scale: green, black, and red
indicating low, medium, and high relative expression levels,
respectively. Coloured bars to the right indicate the location of two
gene clusters: red corresponds to genes with a progressive increase
in mean gene expression level from 2 to 60 dph; and green with
those whose mean gene expression level decreased progressively
from an initial relative high level of expression.
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Regarding RA nuclear receptors, RARA presented at
18 dph a significant up-regulation (1.6 fold change
respect to the control group) in 10×VA larvae with
respect to control fishes (REST, P < 0.05; Figure 8a);
however no significant up- or down-regulation of RARA
was found at 60 dph regardless of the dietary conditions
(REST, P > 0.05; Figure 8a). In contrast, while no
differences in RARG mean gene expression ratio were
found at 18 dph in larvae fed with increased dietary VA
content (1.5×VA and 10×VA), a slight but significant
RARG down-regulation (1.2 and 1.32 fold change,
respectively) was found with respect to control larvae at
60 dph (REST, P < 0.05; Figure 8a). Interestingly, no
change in gene expression was found concerning the
Figure 8 Relative gene expression of RARA, RARB, RXRB and RBP(a), PPARA, PPARB and PPARG (b), Bmp2, TGFB1, IGF1 and IGF2 (c) and
mgp, bglap, SPP1, SPARC and COL1A1 (d) in fishes fed with experimental diets (1.5×VA and 10×VA, 1.00*108 and 6.82*108 total VA IU
kg-1 DW, respectively) at 18 and 60 dph. Relative gene expression measured as the fold change of the target gene with respect to the
house-keeping gene (EF1a) at the appropriate sample time and compared with gene expression in the control group using REST 2008 software.
Gene up- and down-regulations are highlighted in red and green (respectively), using different colour tone to identify each experimental group
and sampled time. Only significantly higher or lower overall gene expression levels are represented (P < 0.05; n = 3 per dietary group).
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gene RXRB at both sample times analyzed (REST, P >
0.05; Figure 8a).
At 18 dph, an inverse correlation between increasing
dietary VA and RBP gene expression was observed
(Figure 8a). Larvae fed with a moderate increase in diet-
ary VA content (1.5×VA) showed a significant up-regu-
lation in the RBP gene expression ratio (1.23 fold
change respect to the control group), whereas those ani-
mals fed with the highest levels of VA in diet (10×VA)
presented a down-regulation with respect to control lar-
vae (1.3 fold change; REST, P < 0.05; Figure 8a). How-
ever, no significant differences in RBP gene expression
ratios were found at 60 dph between experimental
groups (REST, P > 0.05; Figure 8a).
Expression levels of PPARs were also affected by diet-
ary VA levels, however each one to a different extent
(Figure 8b). Larvae fed with higher dietary levels of VA
(1.5×VA and 10×VA) presented a significant down-
regulation in PPARA at both sample times analyzed (18
and 60 dph); up to 1.9 fold change in 10×VA larvae at
18 dph compared with control larvae (REST, P < 0.05;
Figure 8b). In contrast, larvae fed with higher VA diets
showed a significant up-regulation in PPARB gene
expression (up to 1.82 fold change in 10×VA 18 dph lar-
vae) with respect to control larvae (REST, P < 0.05;
Figure 8b), whereas no differences were observed in lar-
vae from the 1.5×VA group at 60 dph. Interestingly,
PPARG showed a contrary effect to the increase of VA
dietary content at 18 dph. While there was a slight sig-
nificant up-regulation in 1.5×VA larvae (1.2 fold change
with respect to control fish; REST, P < 0.05; Figure 8b),
10×VA larvae exhibited a significant down-regulation
(ca. 2.87 fold change with respect to the control group;
REST, P < 0.05; Figure 8b). However, no differences in
gene expression ratio were found in 1.5×VA and 10×VA
larvae at 60 dph (REST, P > 0.05; Figure 8b).
At the end of the feeding phase with high dietary VA
content (18 dph), Bmp2 and TGFB1 did not present sig-
nificantly different gene expression ratios in larvae fed
with supplemented VA diets (1.5×VA and 10×VA) com-
pared with those from the control group (REST, P >
0.05; Figure 8c). This pattern was also observed at 60
dph in 1.5×VA larvae. However, Bmp2 and TGFB1 gene
expression levels were significantly reduced with a 1.57
and 1.5 fold change (respectively) at 60 dph in larvae
fed with the highest dietary VA content (10×VA) with
respect to control larvae (REST, P < 0.05; Figure 8c).
The IGF axis showed different responses to dietary VA
content (Figure 8c). IGF1 gene expression was up-
regulated in larvae fed with higher dietary VA levels at
18 dph (1.4 and 1.6 fold change in 1.5×VA and 10×VA,
respectively) with respect to the control group (REST,
P < 0.05); whereas a significant down-regulation at
60 dph (between 1.11 and 1.14 fold change) in IGF1
transcription was found with respect to the control
group (REST, P < 0.05). Interestingly, IGF2 expression
was not significantly different among experimental
groups at both analyzed sampling times (REST, P >
0.05).
Genes encoding extracellular matrix (ECM) proteins
were also differentially affected by dietary VA content
(Figure 8d). The expression of mgp gene from 1.5×VA
larvae at 18 dph was significantly up-regulated (1.39 fold
change) compared with the control larvae (REST, P <
0.05), while non-significant differences were found in
10×VA larvae (REST, P > 0.05). Conversely, at 60 dph
mRNA levels of mgp in 1.5×VA larvae was no signifi-
cantly different with respect to the control group (REST,
P > 0.05); whereas 10×VA larvae presented a signifi-
cantly lower gene expression ratio (1.5 fold change) than
the control larvae (REST, P > 0.05). Furthermore, the
gene encoding the other Gla protein analyzed (bglap)
showed significantly higher gene expression levels at
18 dph (2.02 and 1.81 fold change in 1.5×VA and
10×VA larvae, respectively) in groups fed with higher
dietary VA content than the control (REST, P < 0.05).
The effect of increasing dietary VA level at 60 dph was
the same in 1.5×VA and 10×VA larvae. Fish from both
treatments showed significant up-regulation on bglap
expression (1.39 and 1.29 fold change) with respect to
control larvae (REST, P < 0.05). In addition, when ana-
lyzing the expression of genes encoding matricellular
proteins, SPP1 did not show significant differences in
1.5×VA larvae with respect to control larvae at 18 dph.
However, a significantly higher gene expression ratio
(1.54 fold change) was found in 10×VA larvae compared
to the control group (REST, P < 0.05). Furthermore,
SPP1 was down-regulated at 60 dph in both larvae fed
with higher VA dietary content (1.48 and 1.78 fold
change in 1.5×VA and 10×VA, respectively) with respect
to the control group (REST, P > 0.05). Interestingly,
SPARC only showed significant differences in expression
in 10×VA larvae at 60 dph with respect to the control
group (REST, P < 0.05), being lower by a 1.28 fold
change. Finally, mRNA levels of COL1A1 were not
affected by the dietary level of VA when compared to
the experimental groups (REST, P > 0.05) at 18 dph.
However, at 60 dph gene expression of COL1A1 was
significantly lower in 1.5×VA and 10×VA larvae (1.45
fold change for both 1.5×VA and 10×VA groups) as
compared to the control group (REST, P < 0.05).
Discussion
The present study analysed the expression profile of sev-
eral gene markers for skeletogenesis during the larval
development in gilthead sea bream, and the influence of
dietary hypervitaminosis A on their expression. Reliable
nutritional, physiological and gene expression results
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can be drawn from this work, as results in growth (dry
weight and standard length) fell within the range of pre-
viously reported values [30,31]. Results from this study
supported the idea that dietary VA content controlled
normal fish development through binding of its active
metabolite, retinoic acid (RA), with specific nuclear
receptors RARs and RXRs, and regulated target genes
expression levels including retinoic receptors themselves.
However, as RNA extractions were obtained from
pooled whole larvae, the expression profiles of each
gene reflect the expression level from a mix of different
cell types and tissues. Thus, the variation of gene
expression ratios observed during larval development
under standard conditions could reflect changes in pro-
portions of different tissues throughout ontogenesis
and/or gene expression regulation in a specific tissue. In
this sense, two different types of gene expression profiles
during gilthead sea bream larval development were
found by hierarchical clustering, showing that transcrip-
tion is time- and tissue-dependent for each gene. For
example, it is evident that higher expression of genes
encoding ECM proteins are correlated with body
growth, as increased fish size requires increasing bone
strength and skeleton size in order to support the
increased body weight. As ECM genes are expressed
only in specific tissues (e.g. skeleton), the disruption of
their tissue and developmental stage dependent expres-
sion by VA could be inferred; whereas it would remain
unclear for the other genes that are ubiquitously
expressed (e.g. IGFs, PPARs, Bmp2 and TGFB1), since
their disruption would be masked by the overall expres-
sion in other tissues.
Retinoid Receptors
The different expression profiles of RARA, RARG and
RXRB found in this study supported the hypothesis that
each gene had a temporal and spatial specific expres-
sion; suggesting specific roles for each of them
[13,32,33]; in which contrasted with the suggested
redundancy among them as found in mouse null mutant
studies [34]. Previous works pointed out that RARA
plays a crucial role in vertebrate RA signalling, being
ubiquitously expressed in embryonic and adult mammal
[35,36] and fish tissues [13]. However, the reported evo-
lution of RARA gene expression in this study is not
in agreement with that found by Villeneuve and co-
workers [13], where European sea bass RARA gene
expression increased from 10 to 42 dph. It is possible
that although both fish species are evolutionarily closely
related, their timing of development is quite different,
which may explain the above-mentioned differences.
Interestingly, the fact that RARA is predominantly
expressed at 5 dph in the jaws of European sea bass
[13], supports the idea that high expression of RARA
observed in 10×VA larvae may be specifically implicated
in the development of jaw deformities detailed in our
previous work [18]. Two factors would explain the high
RARA gene expression found in 10×VA larvae compared
to 1.5×VA and control larvae: (i) the transcriptional acti-
vation of RARA through the presence of a RARE in its
promoter [7], is due to an increase in RA levels; and (ii)
the increased gene expression of Cyp26 enzymes
mediated through RARa receptor, in order to degrade
the excessive RA into other metabolites [37]. Under nor-
mal conditions, chondrogenesis is accompanied by a
decrease in RARA expression [38], a process that nor-
mally takes place at 10 dph in gilthead sea bream. This
result supports the idea that the overexpression of
RARA was dietary induced by an increase of VA, as
reported in fish exposed to Am80 (a RAR-selective ago-
nist [39]), RA [32] or hypervitaminosis A [16]. In addi-
tion, high transcription levels of RARA might be directly
responsible for the disruption of normal patterns of ske-
letogenesis, and could be responsible for the high inci-
dence of skeletal deformities found in fish fed with high
levels of VA [18]. The RARA disruption might have also
activated a downstream gene cascade, including Hoxd-4
and Shh [40] that would also have affected larval mor-
phogenesis [41], and delaying the maturation of the
digestive system as it was found at 18 dph larvae from
the 10×VA group [18]. Furthermore, such differences in
the development of the digestive system were not
observed at 60 dph [18], when VA imbalance was cor-
rected and RARA expression was normalized in relation
to the control group.
The expression pattern of RARG during larval devel-
opment suggests that this gene plays a crucial role in
the transcriptional RA signal regulation during verte-
brate morphogenesis, chondrogenesis and differentia-
tion of squamous epithelia [42,43]. Our results show
that the RARG gene expression ratio was highest
between 37 and 52 dph, which is concomitant with the
onset of the typical adult skin development in gilthead
sea bream; and in concordance with that reported in
European sea bass between 10-42 dph [13]. The modu-
lation of RARG expression by hypervitaminosis A has
been demonstrated in mammals [44] and fishes
[16,17,32]. Nevertheless, no regulation of RARG
expression by hypervitaminosis A was detected in gilt-
head sea bream larvae at 18 dph. This might be due to
the fact that chondrogenesis in chondral bones is
almost completed at that stage of development [9,11],
and RARG is expressed at a lower level in hypertrophic
than in pre-hypertrophic chondrocytes [45]. In contrast
to 18 dph, larvae aged 60 dph exhibited a down-
regulation of RARG in 1.5×VA and 10×VA groups,
which under present experimental conditions seemed
to be linked to different rates of larval development
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(e.g. chondrogenesis and skin differentiation) among
dietary treatments.
The role of RXRs on retinoid signal transduction dur-
ing development of vertebrates depends on each sub-
type. Despite null RXRB or RXRG mutant mice being
viable, and do not display VA associated abnormalities,
RXRA null mutants die [34]. In teleosts, RXRa is
involved in the development of the anterior hindbrain,
tailbud, neural crest, pharynx and fins; whereas RXRb
played different roles in early larval development; and
RXRg plays a key role in brain and nervous system
development and function [26]. In the present study, the
ontogenic increase in expression of RXRB during the
standard experimental trial was in agreement with pre-
viously reported results [16], and it is related to the
development of those tissues where RXRB is mainly
expressed [26]. The expression levels of RXRB in gilt-
head sea bream larvae were not affected by high levels
of dietary VA, which seems to confirm that all-trans-RA
(the most abundant RA isomer in nature) does not bind
to this nuclear receptor nor is it transcriptionally acti-
vated by RAREs [46].
In this study, we present data from gene expression at
specific time points, which is a static representation of a
dynamic process involving the formation of homo- and
heterodimers of the translated proteins leading to down-
stream cascades of gene expression. Variations in RAR-
RXR homo-/heterodimer equilibrium have been shown
to cause severe abnormalities in zebrafish embryos [47].
Thus, abnormal skeletogenesis and/or morphogenesis in
gilthead sea bream could be interpreted as a perturba-
tion of the nuclear RAR-RXR homo-/heterodimer equili-
brium, as higher amount of RARA transcripts could
induce increased formation of RARa-RXR heterodimers
or decreased formation of RXR heterodimers with its
different partners (VDR, TR, PPARs, etc).
Retinol-Binding Protein
Retinol Binding Protein (RBP) is reputed for transport-
ing retinol from the liver to different target tissues [48].
In agreement with previous studies in fish [48] and
other vertebrates [49], RBP gene expression was low
during larval development, and remained constant until
metamorphosis. Such low RBP expression might be due
to either low retinol mobilization requirements during
early fish larval development, or to the fact that the
daily requirements for VA were already fulfilled. There-
fore, retinol mobilization from liver to target tissues was
not needed, and consequently the RBP not transcribed.
When gilthead sea bream larvae were fed with moder-
ately increased levels of VA (1.5×VA group) at 18 dph,
RBP expression was up-regulated, whereas this gene was
down-regulated in fish fed with the highest levels of VA
(10×VA group). Those changes in RBP gene expression
by the dietary VA levels may be due to transcriptional
regulation through the double RARE in its promoter.
Considering that VA homeostasis via its release from
storage tissues is a tightly controlled process [50], we
suggest that the observed RBP gene expression in gilt-
head sea bream larvae in response to dietary VA content
is part of a protective mechanism to avoid VA toxicity.
Under slight dietary hypervitaminosis A (1.5×VA group)
conditions, an increase in RBP mRNA level could be
directly induced by binding of ligand activated RARs
and RXRs to its RARE [51]; whereas during exposure to
elevated VA levels (10×VA group), a decrease in RBP
expression might take place to reduce the mobilization
of VA from the adipose tissue and liver [52].
Peroxisome proliferator-activated receptors
The peroxisome proliferator-activated receptors (PPARs)
are well known fatty acid and eicosanoid inducible
nuclear receptors in vertebrates, playing multiple physio-
logical functions [53]. Molecular studies recently showed
that there exist differences in tissue expression and
ligand-binding properties between fish and mammalian
PPARs [54-56].
Considering that PPARa is implicated in the regula-
tion of fatty acid metabolism [27], the progressive
increase in PPARA expression at late larval stages
seemed to be correlated to larval growth and progressive
differentiation of the liver, intestine and muscle, where
this receptor is mainly expressed [54,57]. However,
PPARA expression was down-regulated when larvae
were exposed to high levels of dietary VA at 18 dph,
which might be linked to the impaired maturation of
the digestive system of 1.5×VA and 10×VA larvae in
comparison to the control group [18]. This is in agree-
ment with [54], PPARA expression being dependant on
the nutritional status of the animal and its changing
energy requirements during development. As PPARa
plays an important role in adipocyte differentiation in
fishes [56], its down-regulation in gilthead sea bream
early juveniles fed with hypervitaminosis A might have
also perturbed the normal differentiation rate of
mesenchymal cells into myogenic, osteogenic and/or
adipocytic cells, leading to skeletal deformities.
PPARb in mammals is involved in the skeletal, brain
and skin functions as well as in adipose tissue differen-
tiation and fatty acid metabolism [58,59]. Its early
expression in gilthead sea bream might be linked to the
mobilization of endogenous reserves stored in the yolk
sac [54] and to the synthesis and turnover of cellular
membranes [60]. However, it did not correlate signifi-
cantly with growth or fat deposition, as it has been pre-
viously reported in cobia (Rachycentron canadum) [57].
Increased expression of PPARB has been described in
the early phase of adipogenesis in mammals [61] and
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red sea bream (Pagrus major) [56]; but in contrast to
mammalian PPARB, its expression in adipocytes did not
seem to be under nutritional control. Primary osteoblas-
tic cells showed a high expression of PPARB [59], then
the higher gene expression of PPARB in 1.5×VA and
10×VA larvae compared to the control group at 18 dph
might indicate a premature osteoblastogenesis in those
groups, as has been suggested in our previous study
[18]. Interestingly, it has been reported that muscle-
specific overexpression of PPARB in mice resulted in a
profound change in muscle fibre composition due to
hyperplasia [62]. Impaired muscle development could in
turn induce some vertebral deformities [63] and lead to
those skeletal deformities (e.g. lordosis) reported in our
previous study [18]. These changes in muscle were
coupled with a reduction in the mass of body fat of
mice [62] that may be in agreement with the gene
expression of the above-mentioned PPARA and PPARG.
In addition, PPARB was up-regulated in 10×VA larvae
at 60 dph, which could reflect a retarded adipogenesis.
It is clear that more research is needed to reveal the
role of PPARb in regulating the muscle fibre growth
and the adiposity of marine fish, as well as the potential
induction of skeletal deformities by such impaired mus-
cle development.
In mammalians, PPARg regulates adipogenesis at its
early phase through heterodimerization with RXR [64].
In fish, it seems that PPARg fulfil the same roles,
although they are not activated by the same specific
ligands [54]. Under normal rearing conditions, PPARG
expression increased with gilthead sea bream ontogen-
esis similarly to data reported in cobia where PPARG
expression increased with fish growth and fat deposition
[57]. However, it has been reported that retinaldehyde
(the metabolic precursor of RA) inhibits PPARG, result-
ing in a lower PPAR-RXR complex formation [65],
which in turn could enhance osteogenesis instead of adi-
pogenesis in mesenchymal cells. Thus, lower PPARG
expression in fish fed with high levels of VA (10×VA
group) at 18 dph could reflect an enhancement of osteo-
genesis and disrupt normal skeletogenesis in gilthead sea
bream larvae. This hypothesis is also reinforced by the
increased blue coloured surfaces (chondrocytes) in both
1.5×VA and 10×VA larvae compared with control
larvae.
Growth Factors
Skeletal cells synthesize different growth factors, such as
fibroblast growth factor, platelet-derived growth factor,
IGFs, TGFb, and additional cytokines. The expression of
IGF1 is found in different soft and calcified tissues in
adult gilthead sea bream [66], where three spliced var-
iants with a specific pattern of expression have been
found [67,68]. Our Taqman assay was designed to
recognise all three IGF1 splice variants; therefore, our
reported gene expression ratio for IGF1 is the sum of
the expression for all three splice variants. In the pre-
sent study, the progressive increase of IGF1 expression
was in accordance with the high cell proliferation rate,
and/or the increase in specific cell activity in different
tissues during larval morphogenesis [66]. The dose-
dependent overexpression of IGF1 found at 18 dph in
gilthead sea bream larvae fed hypervitaminosis A, was in
agreement with previous works [16,69]. The higher
IGF1 expression in the 10×VA group might be due to
synergistic direct and indirect effects. The growth hor-
mone promoter contains a RARE [70], and has been
found to be regulated by RARa/g isoforms in pituitary
cells of carp (Cyprinus carpio; [71]). In turn, increased
RARA expression might induce growth hormone tran-
scription and secretion, which finally would induce an
increase in IGF1 hepatic transcripts. In addition,
increased levels of thyroxin (T4) were observed in fish
under hypervitaminosis A [19], while T4 is reported to
induces IGF1 expression in in vitro fish studies [72].
Then, it seems plausible that the increase in expression
of IGF1 in gilthead sea bream larvae fed with high VA
levels (1.5×VA and 10×VA groups) could be due also to
increased T4 levels. Such high IGF1 expression, which is
known to promote muscle differentiation and growth
[73], coupled with that of PPARB, might have caused an
imbalance in the development of the musculoskeletal
system in gilthead sea bream fed with high levels of VA,
leading to a higher incidence of lordosis in those larvae
[18].
In the present study, the abrupt increase in IGF2
expression recorded at the end of the larval phase (29
dph) corresponds with the onset of ossification in most
of the bone structures [9,11], which is mainly due to its
role in osteoblast proliferation and differentiation [74].
In contrast to IGF1, the expression of IGF2 in gilthead
sea bream fed with hypervitaminosis A was not dis-
rupted, supporting the idea that different hormonal sig-
nals and mechanisms of gene transcription control the
regulation of expression of both IGF forms [67].
Other growth factors such as transforming growth fac-
tors beta (TGFbs) or the bone morphogenetic proteins
(BMPs) are important for the development of bone,
among other tissues [29]. Among those BMP’s, BMP-2
plays a key role in bone development, inducing the dif-
ferentiation of mesenchymal cells into osteoblast precur-
sors and promoting the maturation of osteoblasts
through the expression of Runx2/Cbfa1 [75]. TGFb1 is
involved in the regulation of a broad range of biological
processes, including cell proliferation, differentiation and
migration, production of extracellular matrix [76], as
well as maintaining bone homeostasis and turnover [77].
In our study, the gene expression profile of Bmp2 in
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larvae reared under standard conditions seemed to cor-
relate with the biological function of BMP2. Bmp2
expression between 18 and 22 dph might be associated
with the onset of pre-osteoblasts proliferation [9,11];
whereas the observed tendency of Bmp2 to increase
between 29 and 37 dph might be due to its role as a
promoter of osteoblast differentiation. Furthermore,
increased expression of TGFB1 was concomitant with
an increase in expression of several genes encoding
ECM proteins, as has been reported [76].
Bmp2 expression in early larval stages (18 dph) fed
with hypervitaminosis A was not affected. However, the
possibility cannot be neglected that in those larvae RA
might have disrupted Bmp2 expression prior to our
sampling point, as has been shown in vitro studies [33].
In contrast, Bmp2 was down-regulated in 10×VA larvae
at 60 dph, suggesting a negatively controlled regulation
of Bmp2 [78]. This down-regulation of Bmp2 concomi-
tant with lower RARG gene expression is in accordance
with the reported loss of the RA-inducible expression of
Bmp2 in the absence of RARG gene expression [33].
In addition, the Bmp2 down-regulation might down-
regulate the expression of ECM encoding genes (mgp,
SPP1, SPARC, COL1A1) observed in 10×VA larvae
through the transcriptional regulation of Runx2/Cbfa1
[78].
BMP-2 and TGFb1 have opposing actions on osteo-
blast function and differentiation. While BMP-2
enhances Runx2/Cbfa1 expression, TGFb1 inhibits its
expression; then, both genes regulate the coordinated
expression of several genes encoding ECM proteins [78].
The fact that both genes (Bmp2 and TGFB1) were
down-regulated in gilthead sea bream larvae fed with
hypervitaminosis A (10×VA group) at 60 dph, could be
explained by the ubiquitous expression of TGFB1 which
had a variety of other biological functions and therefore,
this down-regulation of TGFB1 may not be representa-
tive of the skeletal tissue alone.
Genes encoding bone extracellular matrix proteins
Until the beginning of the ossification process at 18 dph
(5.7-6.0 mm standard length; [9], gene expression pro-
files of the genes encoding ECM proteins (mgp, bglap,
SPP1, SPARC and COL1A1) showed low gene expres-
sion values. These results were in accordance with the
ongoing development of most skeletal structures, that
were not yet ossified, with the exception of some located
in the viscerocranial and caudal region [9-11]. Higher
gene expression was found from 37 dph onwards, con-
comitantly with the intense ossification of most of the
bone structures, such as vertebrae centra (9.0-9.4 mm
standard length; [9]). The expression of ECM proteins
progressively increased during larval ontogeny. However,
the significant increases of each gene occurred at
different developmental times, the first to increase being
SPARC and SPP1, followed by mgp, and finally by that
of COL1A1 and bglap, which shows the progression of
gene transcription of specific bone matrix development
markers.
The early increase in expression of SPARC during gilt-
head sea bream ontogenesis reflects the many key pro-
cesses during early larval development in which that
protein is involved, showing an enhanced expression in
areas undergoing chondrogenesis, osteogenesis, somito-
genesis and angiogenesis [79]. SPARC is also reputed for
inhibiting adipogenesis and enhancing osteoblastogenesis
and fibrogenesis in rainbow trout [80], as well as for par-
ticipating in the final mineralization and remodelling of
the ECM. Our increase in SPARC expression during gilt-
head sea bream larval development is in agreement with
that reported in rainbow trout (Oncorhynchus mykiss)
[80], but was contrary to the results found in gilthead sea
bream [79]. Although results are methodologically
incompatible with those of [79] for comparative pur-
poses, the increase in expression of SPARC during early
larval ontogeny would seem more plausible, considering
the participation of SPARC in many biological processes.
Regarding SPP1, its early increased expression might be
attributed to the differentiation of hypertrophic chondro-
cytes and osteoblasts [81].
In mammals, MGP is a decisive factor for differentia-
tion and maturation of chondrocytes and a key regulator
of chondral and intramembranous ossification [82]. In
fish, branchial arches are the sites with higher levels of
mgp expression, followed by the heart, vertebra, kidney
and liver [83]. Thus, increased gene expression during
larval ontogeny in our experiment could reflect the
development of the above-mentioned organs and vital
systems in order to match the biological needs of the
developing larva.
COL1A1 is mainly expressed in connective tissues and
is abundant in bone, cornea, and dermis, and in two cell
types, osteoblasts and fibroblasts. Collagen fibres com-
prise 90% of the ECM proteins in skeletal tissues and
confer most of their physical properties [84]. The pre-
sent ontogeny of the COL1A1 expression was in agree-
ment with previous results found in European sea bass,
where COL1A1 was highly expressed from 31 dph
onwards [14]. According to this data, the earlier increase
in COL1A1 expression in comparison to that of bglap is
in agreement with the temporal coordination of both
ECM encoding genes [85]. Osteocalcin is a specific bone
marker [86] that is required for the correct maturation
of hydroxyapatite crystals during the process of calcifica-
tion [87]. However, the relationship between osteocalcin
and mineralization remains unclear even within the
same species, since some authors detected bglap prior
to mineralization and others at the onset or after the
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beginning of mineralization [82]. Its early detection at 2
dph, in contrast to the previous reported detection in
gilthead sea bream at 37 dph [86], might be linked to
the different molecular techniques used, since qPCR is
more sensitive than Northern blot analysis. This earlier
detection, prior to the development of mature osteo-
blasts and calcification processes, might be linked to its
expression in chondrocytes undergoing chondral calcifi-
cation, as reported in zebrafish [82]. However, the
increase in bglap expression at older stages of develop-
ment (52-60 dph) seemed to be due to the completion
of the ossification of skeletal structures in the axial ske-
leton [9-11,18], similar to that found in European sea
bass [88,89]. Considering that osteopontin and osteocal-
cin are involved in the modulation of hydroxyapatite
crystallization [90], the advanced SPP1 expression might
be related to the inhibition of osteoblast mineralization
[91] occurring in vertebrae centra during their intra-
membranous ossification, thus allowing osteoblast to
maintain their proliferative state; while bglap expression
would be an indicator of the osteoblast mineralization
in those structures [89].
The colour pixel analysis of skeletal structures
revealed that bone development was affected by hypervi-
taminosis A, showing a disequilibrium between bone
and cartilage, as 1.5×VA and 10×VA larvae display
higher amounts of cartilage and lower values of red/blue
coloration ratio with respect to the control group,
respectively. Those lower ratios are in agreement with
higher growth of some cartilage elements leading to the
fusion of caudal fin complex structures [18]. Those dif-
ferences in bone mineralization levels and ossification
processes were reflected by changes in gene transcrip-
tion, describing two different scenarios of mineralization
stage for particular skeletal elements (splanchnocranium,
dorsal and caudal fin elements) depending on the
dietary VA level. Through its active metabolite RA, VA
promotes terminal differentiation of hypertrophic chon-
drocytes [92], which could explain the higher amount of
cartilage tissue in 1.5×VA and 10×VA larvae. Further-
more, mgp over-expression in 1.5×VA larvae at 18 dph
indicated an abnormal development of cartilage, as mgp
has been reported to control bone mineralization [93].
In contrast, high levels of VA in 10×VA larvae induced
advancement of the mineralization process of chondral
structures leading to a higher mineralization stage [18].
Such advanced mineralization could be explained by the
down-regulation of mgp in 10×VA larvae at 60 dph and
the higher expression of SPP1 at 18 dph compared to
control and 1.5×VA larvae, as osteopontin is involved in
osteoblast differentiation [91]. These results are in
agreement with those reported in cell culture studies
[94] and in vivo experiments [4]. At the end of the
study, the down-regulation of SPP1 in 1.5×VA and
10×VA larvae might be considered as another sign of an
abnormal osteoblast development, since SPP1 likely
plays a key role in determining the biochemical proper-
ties of the bone [81]. In addition, another sign of the
advancement of the mineralization process in skeletal
structures in 10×VA larvae was the down-regulation of
SPARC at 60 dph.
Regarding bglap transcriptional regulation, it was up-
regulated at 18 dph in 1.5×VA and 10×VA larval
groups, reflecting an earlier chondral ossification of
some skeletal elements derived from the splanchnocra-
nium (e.g. maxillar, premaxillar, Meckel ’s cartilage,
articular) which are the unique skeletal structures that
were ossifying during that stage of development [11].
This precocious ossification process could be responsi-
ble for the high incidence of deformities in the above-
mentioned structures described in our previous study
[18]. Furthermore, at the end of the study (60 dph), fish
fed with higher levels of VA (1.5×VA and 10×VA)
showed a higher bglap expression than those from the
control group. The over-expression of bglap in the fish
fed hypervitaminosis A indicated an increased ongoing
osteogenic processes, as those larvae presented a higher
amount of osteogenic tissue (sum of red and blue
coloured surfaces) compared to the control group. Con-
sequently, present results suggest that if normal ranges
for bglap expression are established, this gene might be
a reliable marker for detecting disorders in bone forma-
tion and mineralization processes [95,89].
Finally, results of COL1A1 expression were not as
informative as the other analyzed genes from the ECM
regarding the skeletogenesis process. No changes in
gene expression were found in COL1A1 in larvae fed
with hypervitaminosis A at 18 dph compared to the
control group, even though it has been shown that this
gene contains a RARE in its promoter [6]. Different
results from the effects of RA on the expression of
COL1A1 are reported in the literature [6], which sug-
gests an indirect regulation of COL1A1 by RA. However,
larvae from the 1.5×VA and 10×VA groups showed
lower expression of COL1A1 at 60 dph, which seems to
be attributed to the lower expression of RARG detected
in those animals, since this RAR binds specifically to the
RARE of the COL1A1 promoter [84].
Conclusions
The present study showed that the analysed gene
expression patterns in the gilthead sea bream were cor-
related with skeletogenesis during early larval develop-
ment, as they showed a temporally coordinated gene
expression for specific markers of the ECM. Further-
more, results from this study supported the idea that
perturbations in specific dietary nutrients can alter nor-
mal anatomic development mediated by specific genes
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controlled by ligand-receptor interactions. Although
both experimental groups (1.5×VA and 10×VA) were
fed with an excess of VA, there were differences in their
juvenile phenotype depending on the degree of hypervi-
taminosis A. 1.5×VA and 10×VA larvae were fed respec-
tively with moderate and high dietary VA content (1.5
and up to 10 fold increase of VA content in the diet
with respect to the control group). From this we con-
clude, only hypervitaminosis A in the 10×VA group
impaired larval performance in terms of growth, matura-
tion of the digestive system and survival rate, in which
the down-regulation of RBP is illustrative of excessive
dietary VA. However, both doses of VA differentially
affected the coordinated expression of genes during
skeletogenesis, some of them being markers for the dif-
ferences in the processes of chondrogenesis and osteo-
blastogenesis observed among dietary groups at early
stages of larval development (i.e., PPARG and mgp for
1.5×VA; RARA and SPP1 for 10×VA). In particular, the
up-regulation of bglap in 1.5×VA and 10×VA larvae
indicated an advanced ossification in some skeletal
structures. Early disturbance of skeletogenesis were still
manifest after 40 days, as revealed by differences in gene
expression, highlighting the importance of a good nutri-
tional balance during larval development that deter-
mines juvenile phenotype.
Concluding, present results showed that fish are reliable
animal models to study the effects of nutritional hypervita-
minosis A. However, since only global effects of dietary
VA on fish larval physiology could be inferred from this
study due to the use of whole organisms, in vitro research
with bone cell lines is needed to understand the mechan-
isms by which RA controls skeletogenesis.
Methods
Larval rearing and diets
Gilthead sea bream larvae (1 dph) were obtained from a
Spanish private hatchery and shipped to the IRTA facil-
ities. After their acclimation, larvae were distributed at
an initial density of 100 larvae L-1 in 2 and 24 cylindri-
cal tanks, of 500 and 100 L respectively, connected to a
water recirculation unit. Water conditions were as fol-
lows: 18-19°C, 35 ppt salinity, pH 7.8-8.2. Water was
provided with gentle aeration and oxygenation (> 4 mg
l-1) and 20% was exchanged daily. Photoperiod was
12L:12 D, and light intensity of 500 lux at water surface.
All animal experimental procedures were conducted in
compliance with the experimental research protocol
approved by the Committee of Ethic and Animal Experi-
mentation of the IRTA (reference number 621303898-
3898-4-8), which followed the international principles of
replacement, reduction and refinement for the use of
animals in research.
On one hand, in order to characterize gene expres-
sion patterns of selected genes during larval develop-
ment until the juvenile stage, larvae kept in 500 L
cylindrical tanks were reared following a commercial
production procedure. Feeding schedule was as follows:
from day 4 to 20 post hatch (dph) rotifers (Brachionus
plicatilis), whose density was progressively increased
from 5 to 10 rotifers mL-1; Artemia nauplii (EG, INVE,
Belgium) from 16 to 22 dph, in increasing density
from 0.5 to 2 nauplii mL-1, and 2 days enriched-meta-
nauplii from 20 to 40 dph (1 to 5 metanauplii mL-1).
Both live preys were enriched with Easy Selco (ES;
INVE, Belgium) according to manufacturer’s instruc-
tions. From 36 dph to the end of the experiment
(60 dph), larvae were progressively weaned onto dry
feed, first with Proton 1/2 and 1/4 (INVE, Belgium)
and then with Gemma Micro (size range: 75 to 500
μm; Skretting, Spain). On the other hand, larvae kept
in 100 L tanks were reared in order to evaluate the
effects of high dietary VA content on gilthead sea
bream larval performance and quality ([18], as well as
skeletogenesis-related gene expression (present work).
Feeding sequence and dietary experimental conditions
are described in detail in [18]. In brief, three different
dietary regimes (each one in triplicate) were evaluated
during the early larval development (rotifer feeding
phase), containing graded levels of VA. The graded VA
levels in live prey were obtained by adding retinol pal-
mitate (1,600,000 IU g-1, Sigma-Aldrich, Spain) to the
commercial enriching emulsion, Easy Selco™(ES,
INVE, Belgium). Those dietary treatments are referred
to as Control, 1.5×VA and 10×VA; and contained a
mean of 0.66*108, 1.00*108 and 6.82*108 total VA IU
kg-1 DW in enriched rotifers [18], while mean total
vitamin A content in larvae was 60157, 71617 and
72909 IU g-1 DW at 18 dph respectively.
Sample collection
Biological samples were taken at 2, 7, 10, 18, 22, 29, 37,
45, 52 and 60 dph, in order to establish the gene expres-
sion patterns of skeletogenesis-related genes and larval
growth during larval development. In order to evaluate
gene expression regulation by hypervitaminosis A and
bone mineralization, larvae reared under hypervitamino-
sis A were sampled at 18 dph, coinciding with the end
of the nutritional challenge with VA (end of rotifer-feed-
ing phase) and the onset of mineralization of the skele-
ton [9-11], and the end of the weaning period (60 dph).
In all cases, larvae were sacrificed with an overdose of
anaesthetic (Tricaine methanesulfonate, MS-222, Sigma).
In both experiments, samples were frozen in RNA later
(Ambion®) and stored at -80°C until gene expression
analysis.
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Larval growth and bone mineralization
For larval growth, sampled larvae (n = 15) from each
tank were washed with distilled water to avoid marine
salts and used for body length and dry weight determi-
nation. Larval standard length was measured with a
digital camera connected to a binocular microscope
Nikon SMZ 800, AnalySIS (Soft Imaging Systems,
GmbH). Once larvae lengths were measured, they were
dried at 60°C until their weight was constant. Weights
were obtained with an analytic microbalance Sartorius
BP211 D. Thirty larvae per dietary group (ten larvae per
tank) were stained with alcian blue and alizarin red S
[18] in order to evaluate the level of bone mineraliza-
tion under different nutritional circumstances and quan-
tified as described in [22], using a computerized image
analysis package (IMAQ Vision Builder, National Instru-
ments, Austin, TX). Total red and blue pixels were con-
sidered as a marker of the relative ratio of osteoblasts
and chondrocytes (respectively) and normalized by lar-
vae body surface, as larval size were highly variable
within tanks.
RNA extraction and qPCR conditions
Total RNA was extracted from pools of fish larvae (100
to 5 individuals per sample time and tank depending of
fish size) using the TRIzol reagent (Invitrogen®, San
Diego, CA, USA) as specified by the manufacturer. The
quantity of RNA isolated was determined using a Gene-
Quant spectrophotometer (Amersham Biosciences),
measuring optical density at 260 nm and its purity was
established by the absorbance ratio 260/280 nm (1.7-
2.0). The quality of the RNA was examined using 1.2%
agarose gel electrophoresis. A reverse transcription reac-
tion was carried out using equal quantities of total RNA
(1 μg) from each sample and Quanti Tect Reverse Tran-
scription Kit (Qiagen®). Electrophoresis using a 1.2%
agarose gel was run to assess the RT-PCR product.
Real-time qPCR was performed using an ABI PRISM
7300 (Applied Biosystems). For each gene, a species-
specific Taqman assay was designed (Applied Biosystems)
using the sequences acquired from the GenBank database
(Table 1). The efficiency of the Taqman assay for each
gene was previously evaluated to assure that it was close
Table 1 Accession number, primers and probes used for relative quantification of gene expression during gilthead sea
bream ontogenic development and dietary vitamin A nutritional imbalance
Gene name Genebank Component 5’ to 3’ nucleotide sequences
RARA EU643830 Forward CCTGTCTGGACATCCTGATACTTC
Reverse CGTGAGTCCATCTGAGAAAGTCAT
FAM probe CTCTGGTGTGTAGCGTGTAC
RARG EU643831 Forward GTGCGTAATGACAGAAACAAGAAGA
Reverse ACTCCTCTAGCTCTCCACTTAGC
FAM probe CTTTCTGGAAGCACCACCTC
RXRB AM980430 Forward CCTGAGGCCCATGCAATCTC
Reverse ACACACATGCGTTTCTGAGACAA
FAM probe CAGCCCTGGACTAATG
PPARA AY590299 Forward CTTTTCGTGGCTGCCATTATCTG
Reverse CTCCACCAAAGGCACATCCA
FAM probe CCTGGGCGATCTCC
PPARB AY590301 Forward GTTTGTTGCTGCCATCATTCTCT
Reverse CACCTGCTTCACGTTCATTAGC
FAM probe CCGGGACGATCTCCAC
PPARG AY590304 Forward CAATGTCGGCATGTCACACAAC
Reverse CTCCTTCTCCGCCTGGG
FAM probe CCGGCCAAAACGAATG
IGF1 AY996779 Forward GGGCGAGCCCAGAGA
Reverse GCCGTAGCCAGGTTTACTGAAATAA
FAM probe TCCACACACAAACTGC
IGF2 AY996778 Forward GTCGGCCACCTCTCTACAG
Reverse TGCTTCCTTGAGACTTCCTGTTTT
FAM probe TTACCCGTGATGCCCC
Bmp2 AY500244 Forward GTGGCTTCCATCGTATCAACATTTT
Reverse GCTCCCCGCCATGAGT
FAM probe CAGGAGCTCCAAATAA
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to 100%. All reactions were performed in 96 well plates
in triplicate in 20 μl reaction volumes containing: 10 μl
of 2× TaqMan universal PCR master mix (Applied Bio-
systems); 1 μl of the 20× Taqman primer/probe solution
corresponding to the analyzed gene; 8 μl of molecular
biology grade water; and 1 μl of cDNA diluted 1:10, with
the exception of bglap, which was evaluated with straight
dilution. Standard amplification parameters were as fol-
lows: 95°C for 10 min, followed by 45 amplification
cycles, each of which comprised 95°C for 15 s and 60°C
for 1 min. Real time qPCR was performed for each gene,
and therefore, a calibrator sample was included within
each plate.
Data processing
The relative gene expression ratio for each gene was
based on the PCR efficiency (E) and Ct of a sample
compared with the control, and expressed in compari-





  target gene (dCt target gene control sample )
 en
( )
dogenous control gene (dCt  RNA (control sample))EF1 
Statistical differences in gene expression between dif-
ferent developmental stages in larval rearing under stan-
dard conditions were analyzed by ANOVA, while
differences in gene expression ratios between dietary
treatments at each sampled time in larval rearing under
hypervitaminosis A were performed by randomization
tests using REST 2008 software [96].
As reference genes, 18S and EF1a were evaluated as
those have been suggested to be reliable house-keeping
genes for qPCR analyses of developmental processes
[97]. However, results were finally evaluated only with
EF1a as the reference gene, due to the low efficiency of
the 18S Taqman probe (< 90%). In the Control group,
target and housekeeping gene expressions were mea-
sured at 2, 7, 10, 18, 22, 29, 37, 45, 52 and 60 dph using
gene expression at 2 dph as the reference time point, to
establish the normal ontogeny of target gene expression;
while in the excess dietary VA groups (1.5×VA and
10×VA) the relative gene expression of the same target
genes was evaluated at 18 and 60 dph, using the control
group gene expression as the reference.
A supervised hierarchical clustering was applied [98]
to the samples from the larval rearing under standard
Table 1 Accession number, primers and probes used for relative quantification of gene expression during gilthead sea
bream ontogenic development and dietary vitamin A nutritional imbalance (Continued)
TGFB1 AF424703 Forward TTTTCCAACTTCGGCTGTACTGT
Reverse GAGATGCCAAAACTGAAGGTACTGA
FAM probe ATTGCGGCCGTTCTAG
RBP AY550957 Forward TGGCCACCTTCGAGACAAC
Reverse GATGCGGCTCCCCAGTAG
FAM probe CCCCGCCAAGTTCAG
mgp AY065652 Forward CGCCCGAAATACACCTCAGA
Reverse GACGGACGGATACTAGGAGTCTA
FAM probe ACCAGCCGCGACTCG
bglap AF048703 Forward CGAGCACATGATGGACACTGA
Reverse GTCCGTAGTAGGCCGTGTAG
FAM probe CAGCGATGATTCCC
COL1A1 DQ324363 Forward GGCAACAGTCGCTTCACCTA
Reverse CCCCATGTACCGGTGTGT
FAM probe ACGTGCATCCATCCTC
SPP1 AY651247 Forward CCAGCCAGGAGTCAGAGGAT
Reverse ACTCTCATCTGAGTCGCTGTCA
FAM probe CTGCTCTGGCTCTCC
SPARC AJ564190 Forward AAGCTGCACCTCGACTACATC
Reverse CCTTCAGCTCGCTGTCCAT
FAM probe CAGGGCTCGATCATTT
EF1a AF184170 Forward CCCGGTATGGTTGTCACCTT
Reverse GGTGCATCTCCACAGACTTGAC
FAM probe CCCCAGCTGACCACTG
18S TaqMan® Gene Expression Assay\Eukaryotic 18S rRNA, 20X (Part Number 4331182)
18S accession number, forward and reverse primers, as well as probe sequences are not shown as the Taqman assay used is proprietary.
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conditions and each gene was classified according to its
gene expression profile. Tree View software, was used to
generate visual representations of the classification [98].
In order to represent gene expression of target genes
in a more comprehensive manner, gene expression
ratios in larval rearing under hypervitaminosis A were
reported as fold change regulation, and then ratios
between 0 and 1 were transformed and represented as
-1/(target gene ratio).
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